Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)

Autor: Basile, D., Broudin, C., Emile, J.F., Falcoz, A., Pagès, F., Mineur, L., Bennouna, J., Louvet, C., Artru, P., Fratte, S., Ghiringhelli, F., André, T., Derangère, V., Vernerey, D., Taieb, J., Svrcek, M.
Zdroj: In Annals of Oncology June 2022 33(6):628-637
Databáze: ScienceDirect